{
  "nct_id": "NCT90536475",
  "indication": "Asthma",
  "phase": "Phase 2/3",
  "sample_size": 602,
  "duration_weeks": 12,
  "dropout_rate": 0.18,
  "blinding": "single-blind",
  "control_arm": "no control",
  "primary_endpoints": [
    "ACQ score improvement"
  ],
  "secondary_endpoints": [
    "FEV1 improvement",
    "Asthma exacerbation reduction"
  ],
  "outcome_summary": "Benefit-risk profile does not support further development",
  "success": 0,
  "failure_reason": "Unexpected safety signal",
  "start_date": "2021-10-20",
  "completion_date": "2022-01-12"
}